We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 16

Some Canadian biotech companies unhappy with length of FDA approval process
  • Gowling WLG
  • USA, Canada
  • May 29 2008

Canadian biotech companies amongst other countries' companies are reported recently to have been indicating their unhappiness with the speed with which the FDA is approving new drugs.


QLT Inc. up for sale
  • Gowling WLG
  • USA, Canada
  • December 6 2007

On November 27, 2007, Vancouver-based QLT Inc. announced that it has formed a special committee of directors to "review the company's strategic alternatives", which typically means that a company has put itself up for sale.


Josh Hanet
  • Gowling WLG

Michael Crichton
  • Gowling WLG

Michael Herman
  • Gowling WLG

John Norman PhD
  • Gowling WLG



Dale C. Hill
  • Gowling WLG

Mark Kirkey
  • Gowling WLG